Administration of MITA impaired endothelium-dependent vasorelaxation (Fig. 4G–I) and lowered the serum nitrite/nitrate level (Fig. 4J) owing to decreased eNOS activity (Fig. 4K); this suggests that the endothelial dysfunction was exacerbated by MITA in vivo. Here, STING1 is linked to endothelial dysfunction.